Podcast: Medera CEO Ronald Li & Keen Vision CEO and Chairman Kenneth Wong
Innovation in gene therapies is hard, but also potentially ground-breaking and biotechnology firm Medera is taking its decades-long journey in the space to the public markets just as hits its next steps in the clinical process. ...READ MORE
Jackson Acquisition Company II (JACS.U) Prices $200M IPO
Jackson Acquisition Company II (NYSE:JACS.U) announced the pricing of its $200 million IPO and its units are expected to begin trading on the NYSE under the symbol “JACS.U”, Tuesday, December 10 2024. ...READ MORE
Shepherd Ave Capital Acquisition Corporation (SPHAU) Prices $75M IPO
Shepherd Ave Capital Acquisition Corporation (NASDAQ:SPHAU) announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SPHAU”, Thursday, December 5, 2024. ...READ MORE
Tavia Acquisition Corp. (TAVIU) Prices $100M IPO
Tavia Acquisition Corp. (NASDAQ:TAVIU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TAVIU”, Wednesday, December 4, 2024. ...READ MORE
